The Chinese Nightmare: Tesla Vs. BYD – Maintaining Both With A Buy

Summary:

  • I’m pitching China against the U.S. on the EV front comparing BYD versus Tesla.
  • I’m bullish on both, but prefer BYD for the near term as I consider it to have better footing heading out of 2024 considering sales and margins.
  • BYD’s October sales hit a record, and its Q4 is typically strong, suggesting it may surpass Tesla in BEV sales in the near term and regain its position as King.
  • Tesla’s stock also surged post earnings and on Musk’s ties with Trump, making for more limited near-term upside, while BYD offers more near term upside potential as it consolidates Chinese-BEV demand.
  • I hereon share my positive sentiment on BYD and Tesla and how I see EV/BEV demand playing out in the near-term.

Red chiffon on a black background

jcarroll-images/E+ via Getty Images

Investment thesis

The BYD (OTCPK:BYDDF) vs. Tesla (NASDAQ:TSLA) war has officially begun, though it’s been going on longer than the market knows. BYD reported 3Q24 earnings late last month, and everyone and their grandmother reported


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *